COVID-19 Individual Awareness and Education. for Coronavirus
This trial is testing a multilevel intervention to increase acceptance and uptake of COVID-19 vaccines among Latino and African American adults in San Diego. The intervention includes individual awareness and education, linkages to medical and supportive services, and community outreach and health promotion.
- Vaccine Refusal
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How efficacious is COVID-19 Individual Awareness and Education in promoting safety among individuals?
"There is a wealth of evidence demonstrating the safety profile of COVID-19 Individual Awareness and Education, which has been approved by authorities. Therefore, it receives an assessment score of 3."
Are there any volunteer opportunities associated with this research?
"Affirmative. Clinical trials data reveals that this clinical trial, which was initially listed on July 16th 2021, is still recruiting participants. 1000 patients must be enrolled from 6 different healthcare facilities."
Who is eligible to participate in this research project?
"This research project will involve 1000 individuals who have previously refused the vaccine. Eligibility requirements include being aged 18-99, having no history of extreme hypersensitivity reactions to any component of the vaccination, not expecting a child in the upcoming month, biologically male or female with no record of immunological disorder."
Is the age limit for participation in this investigation beyond 30 years of age?
"This clinical trial requires participants to be between 18 and 99 years old. There are 138 studies available for minors, while 908 trials include individuals older than 65."
What is the current enrollment size of this clinical trial?
"Affirmative. According to the research posted on clinicaltrials.gov, this medical investigation is currently searching for 1000 patients at 6 sites and was first released on July 16th 2021 with its most recent edit occuring in mid-December of last year."
What outcomes is this experiment seeking to elucidate?
"This 12-month study seeks to measure changes in Vaccine Hesitancy and will assess secondary outcomes such as Health History, Health Literacy, and Testing & Tracing. Notably, Health History captures data on pre-existing conditions that exacerbate COVID-19 infection such as diabetes mellitus or hypertension; whereas, Health Literacy gauges an individual's ability to find information about symptoms and follow authorities' advice regarding prevention behaviours. Finally, the evaluation of Testing & Tracing looks at barriers and motivations for getting tested while sharing contact details with tracing services. (Adapted from WHO COVID-19 Survey Tool & Guidance)."